Woodline Partners »

Rapt Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9M 322k 8.98
2023-09-30 $831k 50k 16.62
2023-06-30 $935k 50k 18.70
2022-12-31 $5.2M 264k 19.80
2022-09-30 $29M 1.2M 24.06
2022-06-30 $16M 859k 18.25
2022-03-31 $7.9M 358k 21.99
2020-09-30 $2.2M 67k 32.20